Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

The in vitro sustained release profile and antitumor effect of etoposide-layered double hydroxide nanohybrids

Authors Qin LL, Wang M, Zhu RR, You SH, Zhou P, Wang SL

Received 24 January 2013

Accepted for publication 20 March 2013

Published 24 May 2013 Volume 2013:8(1) Pages 2053—2064

DOI https://doi.org/10.2147/IJN.S43203

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Lili Qin,1 Mei Wang,2 Rongrong Zhu,3 Songhui You,1 Ping Zhou,1 Shilong Wang3

1Department of Physical Education, Tongji University, Shanghai, People's Republic of China; 2Department of Chemistry, Tongji University, Shanghai, People's Republic of China; 3School of Life Science and Technology, Tongji University, Shanghai, People's Republic of China


Abstract: Magnesium-aluminum layered double hydroxides intercalated with antitumor drug etoposide (VP16) were prepared for the first time using a two-step procedure. The X-ray powder diffraction data suggested the intercalation of VP16 into layers with the increased basal spacing from 0.84–1.18 nm was successful. Then, it was characterized by X-ray powder diffraction, Fourier transform infrared spectroscopy, thermogravimetry and differential thermal analysis, and transmission electron microscopy. The prepared nanoparticles, VP16-LDH, showed an average diameter of 62.5 nm with a zeta potential of 20.5 mV. Evaluation of the buffering effect of VP16-LDH indicated that the nanohybrids were ideal for administration of the drugs that treat human stomach irritation. The loading amount of intercalated VP16 was 21.94% and possessed a profile of sustained release. The mechanism of VP16-LDH release in the phosphate buffered saline solution at pH 7.4 is likely controlled by the diffusion of VP16 anions from inside to the surface of LDH particles. The in vitro cytotoxicity and antitumor assays indicated that VP16-LDH hybrids were less toxic to GES-1 cells while exhibiting better antitumor efficacy on MKN45 and SGC-7901 cells. These results imply that VP16-LDH is a potential antitumor drug for a broad range of gastric cancer therapeutic applications.

Keywords: layered double hydroxides, etoposide, drug delivery, antitumor effect, sustained release

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Readers of this article also read:

Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles

Rangger C, Helbok A, Sosabowski J, Kremser C, Koehler G, Prassl R, Andreae F, Virgolini IJ, von Guggenberg E, Decristoforo C

International Journal of Nanomedicine 2013, 8:4659-4671

Published Date: 5 December 2013

Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro

Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q

International Journal of Nanomedicine 2013, 8:4091-4102

Published Date: 31 October 2013

The migration of synthetic magnetic nanoparticle labeled dendritic cells into lymph nodes with optical imaging

Su H, Mou YB, An YL, Han W, Huang XF, Xia GH, Ni YH, Zhang Y, Ma JM, Hu QG

International Journal of Nanomedicine 2013, 8:3737-3744

Published Date: 7 October 2013

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo

Qiao C, Zhang K, Jin H, Miao L, Shi C, Liu X, Yuan A, Liu J, Li D, Zheng C, Zhang G, Li X, Yang B, Sun H

International Journal of Nanomedicine 2013, 8:2985-2995

Published Date: 13 August 2013

Fabrication of small-diameter vascular scaffolds by heparin-bonded P(LLA-CL) composite nanofibers to improve graft patency

Wang S, Mo XM, Jiang BJ, Gao CJ, Wang HS, Zhuang YG, Qiu LJ

International Journal of Nanomedicine 2013, 8:2131-2139

Published Date: 7 June 2013

Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage

Srivastava AK, Bhatnagar P, Singh M, Mishra S, Kumar P, Shukla Y, Gupta KC

International Journal of Nanomedicine 2013, 8:1451-1462

Published Date: 15 April 2013

Few-layer graphene sheets with embedded gold nanoparticles for electrochemical analysis of adenine

Biris AR, Pruneanu S, Pogacean F, Lazar MD, Borodi G, Ardelean S, Dervishi E, Watanabe F, Biris AS

International Journal of Nanomedicine 2013, 8:1429-1438

Published Date: 12 April 2013

Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study

Azam A, Ahmed AS, Oves M, Khan MS, Habib SS, Memic A

International Journal of Nanomedicine 2012, 7:6003-6009

Published Date: 5 December 2012

Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophages

Saito S, Tsugeno M, Koto D, Mori Y, Yoshioka Y, Nohara S, Murase K

International Journal of Nanomedicine 2012, 7:5415-5421

Published Date: 10 October 2012

Corrigendum

Jalil MA, Moongfangklang M, Innate K, Mitatha S, Ali J, Yupapin PP

International Journal of Nanomedicine 2012, 7:3279-3280

Published Date: 29 June 2012